Pharmaceuticals: How The Game May Change For Drug Rebates
What the hunt for lost state revenue means for drugmakers.Drug manufacturers need to gear up for tougher rebate collection. Ten more states received their grades on Medicaid drug rebate collection from the HHS Office of Inspector General Feb. 26, with all but three agreeing to implement accounting changes.According to the audits, which are the latest in the OIG's campaign to clean up states' rebate collection process, Kansas, Iowa, Nebraska, Utah, Wyoming and Montana were each found lacking in the controls necessary to ensure money due to Medicaid programs gets actively collected from drug manufacturers.However, Missouri...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: